Based on preclinical data, we designed a phase I/II clinical trial to determine the efficacy and toxicity of doxorubicin followed by paclitaxel in the treatment of advanced breast cancer (either untreated or relapsed after
Patrizia Serra, PhD
Advertisement
Articles by Patrizia Serra, PhD
Advertisement
Latest Updated Articles
- Doxorubicin and Paclitaxel (Sequential Combination) in the Treatment
Published: April 1st 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
SABCS 2025: The Top 5 Takeaways for Breast Cancer Research
2
Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer
3
FDA Grants Fast Track Designation to GPC3x4-1BB Bispecific Antibody in HCC
4
FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC
5